PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-12.95%
Negative net income growth while CSIQ stands at 158.41%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
0.42%
D&A growth of 0.42% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
315.48%
Deferred tax of 315.48% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
-9.36%
Negative yoy SBC while CSIQ is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
75.62%
Well above CSIQ's 36.36% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
-20.95%
AR is negative yoy while CSIQ is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
575.36%
Inventory growth of 575.36% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
-2123.16%
Negative yoy AP while CSIQ is 0.00%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
116.62%
Growth well above CSIQ's 36.36%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
282.25%
Well above CSIQ's 126.30%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
67.36%
Operating cash flow growth below 50% of CSIQ's 171.37%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
8.91%
Some CapEx rise while CSIQ is negative at -1.91%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
We reduce yoy sales while CSIQ is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-82.69%
We reduce yoy other investing while CSIQ is 33.39%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-211.05%
We reduce yoy invests while CSIQ stands at 4.41%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
99.82%
Debt repayment growth of 99.82% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-100.00%
Negative yoy issuance while CSIQ is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
66.05%
We have some buyback growth while CSIQ is negative at -13.16%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.